Fulgent Genetics

Fulgent Genetics R&D per Employee

The R&D Spending per Employee of Fulgent Genetics (FLGT) as of Oct 10, 2026 is 41,465.38 USD. In the previous year, R&D Spending per Employee was 37,550.77 USD — a change of 10.42% (higher).

R&D per Employee

41,465.38USD

YoY

10.42%

Last updated:

R&D Spending per Employee of Fulgent Genetics is 2025 41,465.38 USD. R&D Spending per Employee of Fulgent Genetics was 2024 37,550.77 USD. It decreases by 10.42% higher compared to the previous year.

The Fulgent Genetics R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
4,256.92 USD
Jan 1, 2019
5,028.46 USD
Jan 1, 2020
8,907.69 USD
Jan 1, 2021
18,630.00 USD
Jan 1, 2022
22,238.46 USD
Jan 1, 2023
31,876.92 USD
Jan 1, 2024
37,550.77 USD
Jan 1, 2025
41,465.38 USD
The Fulgent Genetics R&D per Employee history
YEARR&D per EmployeeYoY
41,465.38USD+10.42%
37,550.77USD+17.80%
31,876.92USD+43.34%
22,238.46USD+19.37%
18,630.00USD+109.15%
8,907.69USD+77.15%
5,028.46USD+18.12%
4,256.92USD+31.04%
3,248.46USD+18.69%
2,736.92USD-19.70%
3,408.46USD+750.48%
400.77USD—
Access this data via the Eulerpool API

Fulgent Genetics Stock analysis

What does Fulgent Genetics do? Fulgent Genetics Inc. is a US company founded in 2011 by Jianxing (Justin) Liu and Ming Hsieh. The company has undergone remarkable development and is now active in the field of genomics and genetics. Fulgent Genetics' business model is based on the development and distribution of solutions for the diagnosis of genetic diseases. The company offers a variety of products and services that enable doctors, clinics, and laboratories to make effective diagnoses based on genetics. One of Fulgent Genetics' main divisions is the Clinical Diagnostics department, which offers a wide range of diagnostic products that allow for both molecular diagnoses and the creation of clinical profiles for patients. This enables doctors and clinics to quickly and accurately detect and treat specific diseases. Another important division of Fulgent Genetics is the Research department, which focuses on the discovery and development of new technologies and testing procedures. These technologies and procedures are of great interest to the scientific community and are used in research or clinical studies. Fulgent Genetics also offers a Pharmacogenomics department, which is a growing segment in the personalized medicine market. The goal here is to tailor medications to the patient's genetic makeup. Fulgent Genetics' technology allows for the analysis of a patient's current genetic makeup and recommends medications based on that. Another important area of Fulgent Genetics is the direct-to-consumer sales of tests. This is particularly significant in the field of ancestry and genealogy research. Fulgent Genetics offers a variety of tests in this area and has already achieved great success. Overall, Fulgent Genetics offers a wide range of products and services mainly focused on the diagnosis of genetic diseases. However, the company also goes beyond that and provides solutions for a wide range of customers and applications. Fulgent Genetics is based in the US and has experienced rapid growth since its founding. The company's success is also reflected in the many awards it has received. It has been recognized multiple times and has established a reputation as one of the leading biotechnology companies in the world. Fulgent Genetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fulgent Genetics stock

R&D Spending per Employee of Fulgent Genetics is 41,465.38 USD in 2025.

R&D Spending per Employee of Fulgent Genetics changed from 37,550.77 USD to 41,465.38 USD, representing a 10.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Fulgent Genetics since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Fulgent Genetics historically and in real time.

Access this data via the Eulerpool API

Workforce — Fulgent Genetics

All Key Metrics — Fulgent Genetics